Skip to main content
  • Saved

made a Post

The Efficacy of Bezlotoxumab in the Prevention of Recurrent Clostridium difficile: A Systematic Review

The Efficacy of Bezlotoxumab in the Prevention of Recurrent Clostridium difficile: A Systematic Review

Source :

https://www.cureus.com/articles/103763-the-efficacy-of-bezlotoxumab-in-the-prevention-of-recurrent-clostridium-difficile-a-systematic-review/metrics

Published: August 13, 2022 DOI: 10.7759/cureus.27979 Cite this article as: Thandavaram A, Channar A, Purohit A, et al. (August 13, 2022) The Efficacy of Bezlotoxumab in the Prevention of Recurrent Clostridium difficile: A Systematic Review. Cureus 14(8): e27979. doi:10.7759/cureus.27979 Article reads consist of online article views and PDF downloads.


In conclusion, bezlotoxumab is a great option adjunctive with standard of care CDI antibiotics for the prevention of rCDI in high-risk adults.